VEGFA and B-cell chronic lymphocytic leukemia: Although, results of the first clinical trials evaluating anti-VEGF therapy for patients with CLL indicate a lack of efficacy in patients with relapsed/refractory CLL [38], combining VEGF blocking with conventional treatments may be a potential therapeutic approach for patients with CLL.